000 01832 a2200565 4500
005 20250515120508.0
264 0 _c20080613
008 200806s 0 0 eng d
022 _a1097-0215
024 7 _a10.1002/ijc.23491
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMalek, Anastasia
245 0 0 _aHMGA2 gene is a promising target for ovarian cancer silencing therapy.
_h[electronic resource]
260 _bInternational journal of cancer
_cJul 2008
300 _a348-356 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aApoptosis
650 0 4 _aBlotting, Western
650 0 4 _aCarcinoma
_xgenetics
650 0 4 _aCell Cycle
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
650 0 4 _aCell Survival
650 0 4 _aCystadenocarcinoma, Serous
_xgenetics
650 0 4 _aFemale
650 0 4 _aFlow Cytometry
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGene Silencing
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aHMGA2 Protein
_xgenetics
650 0 4 _aHumans
650 0 4 _aIn Situ Hybridization
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aOvarian Neoplasms
_xgenetics
650 0 4 _aRNA, Small Interfering
_xmetabolism
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTransfection
650 0 4 _aTransplantation, Heterologous
650 0 4 _aUp-Regulation
700 1 _aBakhidze, Elena
700 1 _aNoske, Aurelia
700 1 _aSers, Christine
700 1 _aAigner, Achim
700 1 _aSchäfer, Reinhold
700 1 _aTchernitsa, Oleg
773 0 _tInternational journal of cancer
_gvol. 123
_gno. 2
_gp. 348-356
856 4 0 _uhttps://doi.org/10.1002/ijc.23491
_zAvailable from publisher's website
999 _c17948229
_d17948229